setmelanotide Report issue

Biologics Peptide Orphan Drug FDA Approved FDA Breakthrough Therapy FDA Priority Review FDA

Active Ingredient History

  • Now
Setmelanotide, sold under the brand name Imcivree, is a medication used for the treatment of genetic obesity caused by a rare single-gene mutation.   Wikipedia

  • SMILES: C[C@H]1NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@H](Cc5c[nH]cn5)NC1=O)C(=O)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C
  • Mol. Mass: 1117.33
  • ALogP: Missing data
  • ChEMBL Molecule:
More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
bim-22493 | rm-493 | setmelanotide


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue